GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Trualt Bioenergy Ltd

TruAlt Bioenergy: IPO proceeds utilization confirmed for Q2 2026

RATING ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Aug 2026, 12:10 PM IST  ·  BSE ID: ccf1ec63-9e74-445d-8bd2-70278a985d93
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's IPO money was spent exactly as promised, confirmed by an independent reviewer.
🤖 AI Summary
  • TruAlt Bioenergy's IPO proceeds of Rs 750.00 crore utilization reviewed.
  • Crisil Ratings confirms all proceeds used as per offer document.
  • No deviation from original utilization plan for Q2 2026.
  • No shareholder approval needed for material changes in expenditure.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Gross IPO proceeds
750.00 crore
Net Proceeds
657.04
Quarter ended
June 30, 2026
🏢 How This Affects the Company
📈
Business Impact
Confirms adherence to the IPO object clauses, reinforcing investor confidence in the company's strategic execution.
💰
Financial Impact
Validates the financial planning and management of IPO proceeds, ensuring funds are directed towards stated objectives.
⚙️
Operational Impact
Indicates smooth execution of projects funded by the IPO, aligning with business expansion plans.
⚠️
Risk Impact
Reduces risk associated with fund mismanagement or diversion, strengthening governance perception.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders regarding this filing.
👤
Who Is Affected
All shareholders are affected by the confirmation of proper utilization of IPO proceeds, which impacts corporate governance perception.
🔍
Management Signal
This filing signals management's commitment to transparency and adherence to regulatory compliance regarding IPO fund deployment.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next Monitoring Agency Report for Q3 2026.
Financial results for H2 FY27.
Updates on projects funded by IPO proceeds.
LOW RISK Report confirms no deviations in IPO fund utilization, indicating strong compliance.
💡 Investor Takeaway
TruAlt Bioenergy's Rs 750.00 crore IPO proceeds are confirmed by Crisil Ratings to have been utilized as per the offer document for the quarter ended June 30, 2026, with no deviations.
⚖️ Strengths & Concerns

✅ Positives

  • Consistent IPO fund utilization as per offer document disclosures for Q2 2026.
  • Absence of any material deviations in expenditure requiring shareholder approval.
📅 Company Track Record
Previous monitoring agency reports confirmed IPO funds utilization. India Ratings also assigned IND A- to INR17,660 million bank facilities.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the status of TruAlt Bioenergy's IPO fund utilization for the quarter ended June 30, 2026?
Crisil Ratings confirmed that TruAlt Bioenergy's gross IPO proceeds of Rs 750.00 crore were utilized as per the offer document disclosures.
Were there any deviations in TruAlt Bioenergy's IPO fund utilization?
No, the Monitoring Agency Report states that deviations from the objects are not applicable, and no material deviations requiring shareholder approval occurred.
What was the net proceeds from TruAlt Bioenergy's IPO?
The net proceeds after deducting issue expenses of Rs 92.96 crore from gross proceeds of Rs 750.00 crore were Rs 657.04 crore.
Who is the Monitoring Agency for TruAlt Bioenergy's IPO proceeds?
Crisil Ratings Limited is the Monitoring Agency responsible for monitoring the utilization of TruAlt Bioenergy's IPO proceeds.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.